Superworth

Penumbra EV/EBIT PEN

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2016.

Today, Oct 23, 2026
65.8×
10-year median
93.0×
Against its 10-year history
30th
percentile: 0 is its lowest day, 100 its highest
10-year range
19.6× to 393×
Peer median
17.6×

Penumbra's EV/EBIT is 65.8× as of Oct 23, 2026.

That is below its ten-year median of 93.0×, lower than on 70% of days in the last ten years.

Over that time it ranged from 19.6× in Oct 2025 to 393× in Oct 2016.

The median for 10 medical instruments and supplies stocks of a similar size is 17.6×.

EV/EBIT over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far65.8×26.4×66.9×
202527.0×19.6×125×
2024110×88.0×243×
2023223×161×312×
2022253×247×306×
2021345×286×345×
2020208×73.3×208×
201975.0×62.3×190×
2018151×140×290×
2017n/m a value too high to mean anything
2016393×393×462×

Against its peers

Companies in Medical - Instruments & Supplies nearest Penumbra's size, closest first, today.

CompanyEV/EBIT
PENPenumbra65.8×
COOCooper Companies17.2×
SOLVSolventum8.4×
ALGNAlign Technology16.2×
GMEDGlobus Medical16.3×
PODDInsulet20.4×
MSAMSA Safety18.0×
WSTWest Pharmaceutical Services39.5×
MMSIMerit Medical Systems28.6×
HAEHaemonetics26.8×
VNTVontier10.9×
Peer median17.6×

Where Penumbra ranks

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Penumbra

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.